Tower Research Capital LLC (TRC) - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2018$2,000
-81.8%
1,637
-51.3%
0.00%
-100.0%
Q1 2017$11,000
+266.7%
3,358
+459.7%
0.00%
Q4 2016$3,000600
+769.6%
0.00%
Q1 2016$0
-100.0%
69
-96.5%
0.00%
-100.0%
Q4 2015$8,000
-42.9%
1,989
-46.2%
0.00%0.0%
Q3 2015$14,000
-79.1%
3,694
-74.5%
0.00%
-83.3%
Q2 2015$67,00014,5120.01%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$15,687,0002.68%
Northeast Financial Consultants Inc 732,265$3,105,0001.31%
WEDBUSH SECURITIES INC 15,000$64,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$628,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,752,0000.01%
Virtu KCG Holdings LLC 72,989$309,0000.01%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,555$151,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$64,0000.00%
BlackRock Fund Advisors 612,231$2,596,0000.00%
Spot Trading L.L.C 15,000$64,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders